All News

Although most practices participating in CMS' Oncology Care Model (OCM) are among the most sophisticated in the country, they've run into challenges and have identified areas for adjustment in the 5-year pilot.

Atezolizumab, in combination with chemotherapy, significantly reduced the risk of disease progression and mortality in patients with metastatic triple-negative breast cancer.

Following a federal judge’s decision to block Kentucky's Medicaid work requirements on Friday, Republican Governor Matt Bevin has cut Medicaid dental and vision benefits for 460,000 Medicaid enrollees. The Cabinet for Health and Family Services called the decision "an unfortunate consequence of the judge’s ruling."

Value-based insurance design (VBID) principles were highlighted at 2 congressional hearings as a promising reform to high-deductible health plans (HDHPs).

Researchers in China investigated the prevalence of bronchiectasis in different phenotypes of subjects with COPD and the correlation between bronchiectasis and different phenotypes, especially emphysema.

According to Amgen and Novartis, their calcitonin gene-related peptide inhibitor has demonstrated safety and efficacy in a 1-year study in chronic migraine and reinforced safety and tolerability in a 3-year interim analysis from an ongoing 5-year study in episodic migraine.

Mixed methods research incorporating interviews found a high concordance between patient-reported qualitative data and assessed tumor response in patients with Merkel cell carcinoma.

Collected emergency department (ED) bills show that trauma fees are costly and swing widely; the head of the CDC has changed his mind about opposing the use of condoms and needle programs as ways to stop the spread of sexually transmitted diseases; EDs around the country are struggling with shortages of painkillers and cardiac drugs.

Only 5 fellowship programs in obesity medicine exist today, even though 50 are needed. The partnership will eventually bring the number of programs to 20 nationwide.

Three pain societies have come together to create consensus guidelines for the use of ketamine for both acute and chronic pain.

Children who live in neighborhoods with low walkability may be more likely to develop asthma that will continue through later childhood.

In an interview with Rare Disease Report®, Nicholas J. Robert, MD, of McKesson Specialty Health, discussed the challenges and advances involving treating with treating Merkel cell carcinoma.

Based on trial results that showed glasdegib, an investigational oral smoothened inhibitor, nearly doubled overall survival (OS) in patients with previously untreated acute myeloid leukemia (AML), the FDA has granted the Pfizer drug a Priority Review.

Two recent clinical trials evaluated the efficacy of the investigational drug ozanimod for treating patients with relapsing multiple sclerosis (MS).

In a closely watched case testing an idea pushed by the Trump administration, a federal judge Friday blocked Kentucky’s Medicaid waiver, which required many beneficiaries to work, volunteer, or train for a job as a condition of coverage. Judge James E. Boasberg of Federal District Court for the District of Columbia ruled that CMS' approval of the plan had been “arbitrary and capricious.”

African Americans are still disproportionately affected by HIV compared with other ethnic groups.

CMS is launching a demonstration of its Medicare Advantage Qualifying Payment Arrangement Incentive (MAQI), which pushes Medicare Advantage (MA) providers into taking on more risk. The demonstration, which has to be approved and adopted, would waive Merit-based Incentive Payment System (MIPS) requirements for doctors opting into the new program.

Findings from a 10-year research project show that implementing health initiatives at a population level can improve health and reduce the risk of heart disease for an entire community.

With the American population aging, the healthcare system will need to undergo a transformation, HHS Secretary Alex Azar said when he spoke before the Health Care Association/National Center for Assisted Living.

This week in managed care, the top stories included HHS Secretary Alex Azar appearing before the Senate Committee on Finance to discuss the administration's plan to drive down prescription drug prices; FDA Commissioner Scott Gottlieb, MD, calling on payers to share data to aid drug innovation; and CMS calling for stricter oversight of Medicaid.

We've rounded up the top 5 most read articles of June, including trial results from the 2018 American Society of Clinical Oncology Annual Meeting and a FDA breakthrough therapy designation for a gene therapy.

Drug manufacturer AbbVie, and a nonprofit drug discovery division of Scripps Research, Calibr, announced earlier this week that they are partnering to develop chimeric antigen receptor (CAR-T) cell therapies primarily aimed at treating cancer, particularly, solid tumors.

Coverage of our peer-reviewed research and news reporting in the healthcare and mainstream press.

The California state legislature approved a last-minute deal to halt soda taxes for 12 years; the Department of Justice charged 601 people for taking part in a variety of frauds and schemes that resulted in more than $2 billion in healthcare losses; Amazon buying PillPack, an online pharmacy, is exactly what the pharmacy business has been fearing.

A new study conducted at the Karolinska Institutet in Sweden has discovered an epigenetic regulatory mechanism of the human leukocyte antigen (HLA) region of the DNA, which can lead to an increased risk of multiple sclerosis.

Real-world evidence received lots of attention as drug makers looked to compare therapies within a class.

From making the Oncology Care Model work to the challenges of paying for CAR T-cell therapy, panelists at the National Comprehensive Cancer Network Policy Summit discussed how the cost of innovation affects decisions.

The American Medical Group Association has endorsed a set of 14 value measurements to streamline the reporting process and reduce costs while also improving care by offering a standard set of measures for value-based contracts with payers.

While it is known that heightened estrogen levels are linked to an increased prevalence of migraine in women, new research suggests that the hormone plays an equally important role in causing migraine among men.

Payers have been rolling out disease management programs as a way to both control costs and improve outcomes for patients with chronic diseases, such as chronic obstructive pulmonary disease, asthma, diabetes, and others. But what happens to health outcomes when components of care considered COPD disease management in the United States are considered part of usual care elsewhere in the world?